The experience of relapsed Burkitt lymphoma treatment with targeted drugs and autologous/allogeneic stem cell transplantation
The use of high-effective, multicomponent, risk-adopted chemoimmunotherapy schemes in children with Burkitt lymphoma reached advanced long-term progression-free survival over 90 % even for high risk patients. Unfortunately, conventional therapeutic strategy for relapsed/refractory disease is not acc...
Saved in:
| Main Authors: | T. T. Valiev, A. A. Khachatryan, S. V. Goryacheva, N. A. Batmanova, K. I. Kirgizov, S. R. Varfolomeeva |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2024-01-01
|
| Series: | Онкогематология |
| Subjects: | |
| Online Access: | https://oncohematology.abvpress.ru/ongm/article/view/896 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A clinical case of immune-mediated pneumonitis after nivolumab in a patient with Burkitt lymphoma
by: K. I. Utesheva, et al.
Published: (2023-03-01) -
Case report: A novel third-generation anti-CD19/CD22 CAR T-cells combined with auto-HSCT for relapsed Burkitt lymphoma
by: Xiaodan Luo, et al.
Published: (2024-12-01) -
Burkitt lymphoma with heart involvement: features of diagnosis, treatment and follow-up
by: G. A. Radzhabova, et al.
Published: (2025-03-01) -
Very late relapse of Burkitt's lymphoma in an EBV-negative patient after 20 years of complete remission
by: Kmar Mrad, et al.
Published: (2024-01-01) -
Atypical presentation of oral Burkitt lymphoma in an adult: a case report
by: Rajae El Gaouzi, et al.
Published: (2024-12-01)